compared to total revenue from medical treatment for the fiscal year 2018 and 2019, equaled to 70.5% and 81.4% respectively. The major proportion in cost of medical treatments were derived from cost incurred
first quarter of year 2018 compared to the same period of prior year are as follows; The Group reported total revenues (excluded other revenues) at THB 168.2 million, decreased by THB 72.8 million or 30.2
first quarter of year 2019 compared to the same period of prior year are as follows; The Group reported total revenues (excluded other revenues) at THB 188.8 million, increased by THB 20.7 million or 12.3
”) for the first quarter of year 2020 compared to the same period of prior year are as follows; The Group reported total revenues (excluded other revenues) at THB 177.4 million, decreased by THB 11.4
% with costs of sales and services of ฿ 133.87 million, a ฿ 46.08 million or 25.61 % decrease. Therefore, the company’s total operating results for the three-month period which ended on March 31, 2019 have
larger proportion. Therefore, the company’s total operating results for the six-month period which ended on June 30, 2019 have profited as of ฿ 0.99 million while loss for the same six-month period last
decreased by a larger proportion. Therefore, the company’s total operating results for the nine-month period which ended on September 30, 2019 have profited as of ฿ 5.80 million while loss for the same nine
. The SEC has significantly improved the level of implementation of the IOSCO Principles, with 35 out of the total 37 areas being assessed as fully or broadly implemented. Such results reflect that the
the prior year are as follows; For the year 2017 the Group reported total revenues at THB 826.7 million, decreased by THB 142.2 million or 14.7% when compared to the prior year. It mainly decreased from
Baht 2017 2016 Change between YoY Amount % Amount % Amount % Revenues from medical services 391.84 97.29 339.83 97.01 52.00 15.30 Other revenues 10.91 2.71 10.46 2.99 0.45 4.30 Total revenues 402.74